MedTrace Logo

Insulin Delivery Using Microneedles in Type 1 Diabetes

NCT00837512 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2014-01-08

Study results available
· View outcomes & findings →

Summary

The goal of this study is to determine if microneedles can effectively and painlessly deliver insulin to children and young adults with type 1 diabetes.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

Microneedle

Microneedle used to deliver insulin at a depth less than 900 micrometers

DEVICE

Subcutaneous insulin catheter

Subcutaneous insulin catheter used to deliver insulin at a depth of 9 mm (9000 micrometers)

Sponsors & Collaborators

  • Thrasher Research Fund

    collaborator OTHER

  • Emory University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2012-12-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00837512 on ClinicalTrials.gov